BAVENCIO (avelumab) injection

BAVENCIO is a brand-name prescription drug that’s FDA-approved to treat • Merkel cell carcinoma (a type of skin cancer) • Renal cell carcinoma (a type of kidney cancer) & • Urothelial cancer (a type of cancer in the bladder or urinary tract). Brand Name: BAVENCIO (avelumab) injection, for intravenous use Initial U.S. Approval: 2017.

BAVENCIO (avelumab) injection In India and Overseas
BAVENCIO (avelumab) injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Overseas Patient/ Export inquires.

Call / WhatsApp Number
+91 9643240915 (Mr. Yashpal Singh)
+91 9289711087 (Ms. Sana Sadyar)

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

BAVENCIO (avelumab) injection

Avelumab is approved to treat: • Merkel cell carcinoma (a type of skin cancer) • Renal cell carcinoma (a type of kidney cancer) & • Urothelial cancer (a type of cancer in the bladder or urinary tract). Avelumab is also being studied in the treatment of other types of cancer.

BAVENCIO is a prescription medicine used to treat:
• a type of skin cancer called Merkel cell carcinoma (MCC) in adults and children 12 years of age and older.
• a type of cancer in the bladder or urinary tract called urothelial carcinoma (UC).
• a type of kidney cancer called renal cell carcinoma (RCC).

Avelumab, A drug that binds to the protein PD-L1 to help immune cells kill cancer cells better and is used to treat different types of cancer. Avelumab is used alone or with other drugs to treat certain types of advanced renal cell carcinoma (a type of kidney cancer), urothelial cancer (a type of cancer in the bladder or urinary tract), and Merkel cell carcinoma (a rare type of skin cancer). It is also being studied in the treatment of other types of cancer. Avelumab may block PD-L1 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called Bavencio. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/avelumab

Drug (Brand / Generic): BAVENCIO / avelumab
Current Indications: • Merkel cell carcinoma • Renal cell carcinoma & • Urothelial cancer
Marketed by:: EMD Serono, Inc. and Pfizer Inc
Approval Date: 2017

Available as (Form & Strength): Injection: 200 mg/10 mL (20 mg/mL) solution in single-dose vial. BAVENCIO (avelumab) Injection is a sterile, preservative-free, and clear, colorless to slightly yellow solution for intravenous infusion supplied as a single-dose vial of 200 mg/10 mL (20 mg/mL), individually packed into a carton (NDC 44087-3535-1).

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.